Åwªï¥úÁ{ ³¢¬P§g ¦Ñ®v­Ó¤H¾Ç³N¬ã¨sºô­¶
°ò¥»¸ê®Æ
©ÒÄݨt©Ò¡G
Å@²z¨t  °òÂå²Õ±Ð¬ã·|  ±M¥ô  ±Ð±Â  ( ¹Å¸q®Õ°Ï )
­^¤å©m¦W¡G
Kuo,Hsing-Chun  
³Ì°ª¾Ç¾ú¡G
¤¤¤sÂå¾Ç¤j¾Ç ¥Í¤Æº[¥Íª«¬ì§Þ¬ã¨s©Ò ³Õ¤h 
¿ì¤½«Ç¡G
ªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡ A´É 6F 606 
Ápµ¸¹q¸Ü¡G
(05)362-8800#2606 
¹q¤l¶l¥ó¡G
kuohc@mail.cgust.edu.tw 
±Mªø»â°ì¡G
1. ¥Íª«¤Æ¾Ç»PÁ{§É¥Í¤Æ¡@2. ·L¥Íª«§K¬Ì¾Ç»PÁ{§ÉÀËÅç¾Ç¡@3. ³J¥Õ½èÅé¾Ç¡@4. ¤À¤l¸~½F¾Ç¡@ 
¬ã¨s¿³½ì¡G
1.¤j¸zª½¸zÀù³J¥Õ½èÅé¬ã¨s¡@2. ¥\¯à©Ê³J¥Õ½èÅé¤èªk±´¯Á¤£¦P¯e¯f¤§¬ã¨s¡@3. °ò¦]ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s¡@4. ¤ÑµMª«µÑ¨ú¯Â¤Æ»P¥\®Ä¶}µo¡@ 

¹ê°È¸gÅç¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
¾Ç´Á
¸g¾úÃþ«¬
¤u§@¾÷ºc
°_©l¤é´Á
²×¤î¤é´Á
095 
·~¬É±M­Ý¾¤u§@¸gÅç 
°ê®a½Ã¥Í¬ã¨s°| 
2006/12/29 
2007/02/28 
095 
·~¬É±M­Ý¾¤u§@¸gÅç 
ªø©°Âå°| 
2007/03/27 
2008/08/01 
103 
²£¾Ç¦X§@­pµe®× 
¸²µå¤ý¥Í§ÞªÑ¥÷¦³­­¤½¥q 
2014/11/01 
2016/10/31 

¬ÛÃöÃÒ·Ó¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
¾Ç´Á
ÃÒ·ÓÃþ«¬
ÃÒ·Ó¦WºÙ
089 
±M§Þ°ª´¶¦Ò 
Âå¨ÆÀËÅç®vÃҮѠ
098 
¨ä¥L¬ÛÃöÃÒ·Ó 
¦Ò¸Õ¤Î®æÃÒ®Ñ-¤HÅé¸ÕÅç¬ã¨s­Û²z»{ÃÒ¦Ò¸Õ 
098 
¨ä¥L¬ÛÃöÃÒ·Ó 
¦Ò¸Õ¤Î®æÃҮѢw¤HÅé¸ÕÅç¬ã¨s­Û²z¶i¶¥»{ÃÒ¦Ò¸Õ 
099 
¨ä¥L¬ÛÃöÃÒ·Ó 
¤HÅé¸ÕÅç¬ã¨s¤H­ûÁ¿²ß¯Z°V½mÃÒ©ú 

±M·~ªA°È¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
®×¸¹
®×¦W
®Õ¤º/®Õ¥~
ªA°È¼t°Ó
ªA°È©Ê½è
¥Í®Ä¤é´Á
²×¤î¤é´Á
098 
 
 
 
¹Å¸qªø©°Âå°|¤ú¬ì  
¨ä¥L¡GÁܽлY°|ºtÁ¿¤Î«ü¾É Stem Cells and Bone Generation  
2010/02/23 
 
099 
(99)¹ÅÅ@ªAÃÒ¦r²Ä0020¸¹ 
·P¬VÂå¾ÇÁ{§É·ÓÅ@¤Î²Î­p¤ÀªR¬ã¨sªÀ¸s 
 
ªø©°§Þ³N¾Ç°| 
¨ä¥L¡G®v±Ð¾Ç¼W¯àªÀ¸s¥l¶°¤H 
2010/08/01 
2011/01/31 
099 
 
 
 
°ê¥ß¤¤¥¿¤j¾Ç ¥Í©R¬ì¾Ç¨tº[¤À¥Í©Ò¡B¥ÍÂå©Ò 
¨ä¥L¡G»Y®ÕºtÁ¿: ¦A¥ÍÂå¾Ç¤§À³¥Î 
2010/10/08 
 
099 
 
 
 
°ê¥ß»OÆW®ü¬v¤j¾Ç¥Í©R¬ì¾Ç°|­¹«~¬ì¾Ç¨t 
¨ä¥L¡G±MÃDºtÁ¿ 
2011/03/31 
 
100 
 
 
 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G±Ð®v±Ð¾Ç¼W¯àªÀ¸s¥l¶°¤H 
2012/02/13 
 
101 
 
 
 
ªø©°ÂåÀø°]¹Îªk¤H¹Å¸qªø©°¬ö©ÀÂå°|°ü²£¬ì 
¨ä¥L¡G·F²Ó­M©ó°ü²£¬ìªº¬ã¨s 
2012/08/17 
 
101 
 
 
 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G·P¬VÂå¾Ç¥Íª«¼Ð»x»PÁ{§É·ÓÅ@¬ã¨sªÀ¸s¥l¶°¤H 
2012/09/01 
 
101 
 
 
 
BMC CANCER 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2012/09/19 
 
101 
 
 
 
ªø©°ÂåÀø°]¹Îªk¤Hªø©°¬ö©ÀÂå°|°ª¶¯°|°Ïª½¨z¬ì 
¨ä¥L¡G¥H³J¥Õ½èÅé¤èªk±´¯ÁÍÁତƦX¤Æ¦Xª«§Ü¤j¸zª¢¤§¬¡©Ê¬ã¨s 
2012/10/05 
 
101 
 
 
 
Pharmaceutical Biology 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2012/10/17 
 
101 
 
 
 
ªø©°ÂåÀø°]¹Îªk¤H°ª¶¯ªø©°¬ö©ÀÂå°|¥~¬ì³¡ 
¨ä¥L¡G¸ó»â°ì¾ã¦X«¬¬ã¨s¤èªk¤§²{ªp»P¥¼¨ÓÁͶՠ
2012/11/14 
 
101 
 
 
 
¦æ¬F°|°ê­x°h°£§Ð©x§L»²¾É©e­û·|»O¤¤ºa¥ÁÁ`Âå°| 
¨ä¥L¡G¤À¤lÂå¾ÇÀËÅ礧¾ã¦X©Ê¬ã¨s¤èªk 
2012/11/28 
 
101 
 
 
®Õ¤º 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G·P¬VÂå¾Ç¥Íª«¼Ð»x»PÁ{§É·ÓÅ@¬ã¨s¸s¥l¶°¤H 
2013/03/01 
 
101 
 
 
®Õ¥~ 
¸²µå¤ý¥Í§ÞªÑ¥÷¦³­­¤½¥q 
¨ä¥L¡GµUÀYÛ£µo»Ãµßµ·Å餧µÑ¨úª«©µ½w°I¦Ñ¥\¯àµû¦ô¸ÕÅç 
2013/03/06 
 
101 
 
 
®Õ¥~ 
Food and Chemical Toxicology 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2013/03/20 
 
101 
 
 
®Õ¥~ 
Journal of Physiology and Pharmacology 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2013/05/07 
 
101 
 
 
®Õ¥~ 
¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| 
¨ä¥L¡Gµoªí¡uµUÀYÛ£¬ÛÃö¬ã¨s¡vºt»¡ 
2013/05/26 
 
101 
 
 
®Õ¥~ 
¦æ¬F°|°ê­x°h°£§Ð©x§L»²¾É©e­û·|¥x¤¤ºa¥ÁÁ`Âå°| 
¨ä¥L¡G¤ÑµMÃĪ«§Ü¤j¸zÀùªº¾÷Âà 
2013/06/19 
 
102 
 
 
®Õ¤º 
°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡Å@²z¨t 
¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡Å@²z¨t±Ð®v¾Ç³Nº[¬ã¨sµo®i²Õ²Õªø 
2013/08/01 
 
102 
 
 
®Õ¥~ 
°]¹Îªk¤H¥xÆW¤À¤lÂå¾Ç·| 
¨ä¥L¡G¾á¥ô²Ä¤T©¡²Ä¤G¦¸·|­û¤j·|º[¾Ç³N¬ã°Q·|ºtÁ¿ªÌ 
2013/09/15 
 
102 
 
 
®Õ¥~ 
°ê¥ß¹Å¸q¤j¾Ç 
¨ä¥L¡G±MÃDºtÁ¿_ÃĥίuµßµUÀYÛ£¶}µo¦b­¹«~°·±d¤äÀ³¥Î 
2013/10/07 
 
102 
 
 
®Õ¥~ 
World Journal of Gastroenterology 
¨ä¥L¡G¾á¥ô°ê»Ú´Á¥Z½s¼fªA°È 
2013/10/20 
 
102 
 
 
®Õ¥~ 
World Journal of Gastroenterology 
¨ä¥L¡G¾á¥ô°ê»Ú´Á¥Z½s¼fªA°È 
2013/11/18 
 
102 
 
 
®Õ¤º 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¥Á¥Í¾Ç°| 
¨ä¥L¡G¾á¥ô¥Á¥Í¾Ç°|¥Á¥Í²£·~¬ãµo¤¤¤ßÅU°Ý 
2014/02/01 
 
102 
 
 
®Õ¥~ 
¤¤µØ¤t±T¯gÃöÃh¨ó·| 
¨ä¥L¡G¾á¥ô¨ó·|²Ä¤@©¡ ²z¨Æ 
2014/02/15 
 
102 
 
 
®Õ¥~ 
Tumor Biology 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2014/03/06 
 
102 
 
 
®Õ¥~ 
Integrative Cancer Therapies 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2014/03/14 
 
102 
 
 
®Õ¥~ 
¹Å¸q¿¤¤»¸}¶m§ó¼d°ê¥Á¤p¾Ç 
¨ä¥L¡G¾á¥ôÁ¿®y 
2014/04/23 
 
102 
 
 
®Õ¥~ 
°ê¥ß¹Å¸q¤j¾Ç¥Í¤Æ¬ì§Þ¾Ç¨t 
¨ä¥L¡G¬ã¨s©ÒºÓ¤h¥Í³¢Âí¹ü½×¤å«ü¾É±Ð±Â 
2014/07/16 
 
102 
 
 
®Õ¥~ 
°ê¥ß¹Å¸q¤j¾Ç¥Í¤Æ¬ì§Þ¾Ç¨t 
¨ä¥L¡G¥Í¤Æ¬ì§Þ¾Ç¨t¬ã¨s©ÒºÓ¤h¥Í±i³ÍÓ}½×¤å«ü¾É±Ð±Â 
2014/07/16 
 
103 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡¶i­×³¡¤G¦~¨î¤@¦~¥|¯Z¾É®v 
2014/09/01 
 
103 
 
 
®Õ¥~ 
¹Å¸qªø©°¬ö©ÀÂå°| ¾ã§Î¥~¬ì 
¨ä¥L¡G¾á¥ôÁ¿®y 
2014/09/23 
 
103 
 
 
®Õ¥~ 
°ê¥ß¤¤¥¿¤j¾Ç¥Í¥Í©R¬ì¾Ç¨t 
¨ä¥L¡G±MÃDºtÁ¿ 
2014/10/17 
 
103 
 
 
®Õ¥~ 
°ª¶¯¥«¥ß¤¤¤s°ª¯Å¤¤¾Ç 
¨ä¥L¡G¶i¦æ±MÃDºtÁ¿ 
2014/10/25 
 
103 
 
 
®Õ¥~ 
¥xÆW¤À¤lÂå¾Ç·| 
¨ä¥L¡G¾á¥ô2014¦~·|­û¤j·|º[¾Ç³N¬ã°Q·|Á¿ªÌ 
2014/11/09 
 
103 
 
 
®Õ¥~ 
À¹¼w´ËÂåÀø°]¹Îªk¤H¹Å¸q°ò·þ±ÐÂå°| 
¨ä¥L¡G¬ã¨s­pµe¼f¬dªA°È 
2015/05/31 
 
104 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G¾á¥ô¹Å¸q¤À³¡²£¾Ç¦X§@µo®iº[°ê»Ú¥æ¬y©e­û·|¥D©e 
2015/08/01 
 
104 
 
 
®Õ¥~ 
Journal of Cellular and Molecular Medicine. 
¨ä¥L¡GReviewer ½×¤å¼f¬d 
2015/08/04 
 
104 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¨ä¥L¡G¾á¥ô±Ð¨ô­pµe¡uªø©°®v¥Ítalk show¡v-¡u¦æ¨ì¤ô½a³B¡B§¤¬Ý¶³°_®É¡G§Úªº¾Ç«ä¾úµ{¡vÁ¿®v 
2015/10/06 
 
104 
 
 
®Õ¥~ 
¹A·~¥Í§Þ¤ÀªR»P«P¶i¿ì¤½«Ç 
¨ä¥L¡G¾á¥ô¬ì§Þ³¡·s¹A·~¥Í§Þ²£¾Ç´C¦X·|Âå¹A¸ó»â°ì¨t¦C¡G°·±d­¹«~²£·~Á¿ªÌ 
2016/07/25 
 
105 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G­Ý¥ô¹Å¸q¤À³¡Å@²z¨t²£¾Ç¦X§@µo®iº[°ê»Ú¥æ¬y©e­û·| 
2016/08/01 
 
105 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B 
¨ä¥L¡G¹êÅç°Êª«·ÓÅ@¤Î¨Ï¥Î¤p²Õ©e­û 
2016/11/01 
 
105 
 
 
®Õ¥~ 
°¨°ºÂåÅ@ºÞ²z±M¬ì¾Ç®Õ 
¨ä¥L¡G¡u²£¾Ç¬ã²ß¡vÁ¿®v 
2016/12/13 
 
105 
 
 
®Õ¥~ 
¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| 
¨ä¥L¡G©ó¡u²Ä¤­©¡§Þ³N³Ð§@¤j½à¡vµoªíºt»¡ 
2017/06/11 
 
106 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G¾á¥ô106-107¾Ç¦~«×¹Å¸q¤À³¡Å@²z¨t±Ð®vµû¼f©e­û·| 
2017/08/01 
 
106 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¨ä¥L¡G¨ó§UŪ®Ñ·|¤u§@ 
2017/08/01 
 
106 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¨ä¥L¡G¾á¥ô¾Ç«ä¾úµ{¸gÅç¤À¨É·|Á¿ªÌ 
2017/11/21 
 
106 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¨ä¥L¡G¨ó§UŪ®Ñ·|¤u§@ 
2018/02/01 
 
106 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¨ä¥L¡G­t³d107¾Ç¦~«×±Ð¨|³¡°ª±Ð²`¯Ñ­pµe1-1-A«p´Ó¾Ç¥Í°ò¦¯à¤O¡A¨Ã¾á¥ô­pµe¥D«ù¤H¡C 
2018/02/01 
 
106 
 
 
®Õ¥~ 
¬ì§Þ³¡ 
¾á¥ô¬F©²¾÷ºc±M·~©e­û·|©e­û 
2018/02/01 
 
107 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¨ä¥L¡G¾á¥ô107¾Ç¦~«×¹Å¸q¤À³¡Å@²z¨t±Ð®vµû¼f©e­û·|©e­û 
2018/08/01 
 
107 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¨ä¥L¡G¨ó§U¡uŪ®Ñ·|¡v¤u§@ 
2018/08/01 
 
107 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾ÇÀô¹Ò¦w¥þ½Ã¥Í«Ç 
¨ä¥L¡G¾á¥ô¥Íª«¦w¥þ·|©e­û 
2018/08/01 
 
107 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G¾á¥ô¹êÅç°Êª«·ÓÅ@©e­û¤Î¨Ï¥Î¤p²Õ©e­û 
2018/08/01 
 
107 
 
 
®Õ¥~ 
¤¤¤sÂå¾Ç¤j¾Ç 
¨ä¥L¡G¾á¥ôÂå¾ÇÀ³¥Î¤Æ¾Ç¨tºÓ¤h¯Z¬ã¨s¥Í½×¤å¤f¸Õ¤§¦Ò¸Õ©e­û 
2019/01/22 
 
107 
 
 
®Õ¥~ 
¬ì§Þ³¡ 
¾á¥ô¬F©²¾÷ºc±M·~©e­û·|©e­û 
2019/02/01 
 
107 
 
 
®Õ¤º 
ªø©°¤j¾Ç 
¨ä¥L¡G¾á¥ôªø©°¤j¾Ç107¾Ç¦~«×²Ä¤G¾Ç´Á³Õ¤h¯Z¬ã¨s¥Í¾Ç¦ì¦Ò¸Õ¦Ò¸Õ©e­û 
2019/06/27 
 
107 
 
 
®Õ¥~ 
°ê¥ß°ª¶¯¬ì§Þ¤j¾Ç 
¨ä¥L¡G¾á¥ô107¾Ç¦~«×²Ä2¾Ç´ÁºÓ¤h¯Z¬ã¨s¥Í¾Ç¦ì¦Ò¸Õ©e­û 
2019/07/31 
 
108 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç 
¨ä¥L¡G108¡B109¾Ç¦~«×¾­û¥Ó¶Dµûij©e­û·|©e­û 
2019/08/01 
 
108 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¨ä¥L¡G¨ó§U¡uŪ®Ñ·|¡v¤u§@ 
2019/08/01 
 
108 
 
 
®Õ¤º 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡ 
¨ä¥L¡G¾á¥ô¾Ç¥ÍªÀ¹Î¡u¼²²yªÀ¡v«ü¾É¦Ñ®v 
2019/08/01 
 
108 
 
 
®Õ¥~ 
°ª¶¯¥«¤¤¤s°ª¯Å¤¤¾Ç 
¨ä¥L¡G±MÃDºtÁ¿ 
2019/09/24 
 
108 
 
 
®Õ¥~ 
¤¤¤sÂå¾Ç¤j¾Ç 
¨ä¥L¡G¾á¥ô108¾Ç¦~«×¸ó»â°ì¾Çµ{³Ð·s³Ð·N³Ð·~¤u§@§{ 
2019/10/30 
 

¾Ç³N¬¡°Ê¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
¬¡°Ê¦WºÙ/¶i­×½Òµ{
¥D¿ì³æ¦ì/¶i­×¾÷ºc
¬¡°ÊºØÃþ
¬¡°Ê«¬ºA
¬¡°Ê¦aÂI
°Ñ»P±¡§Î
¶}©l¤é´Á
µ²§ô/§¹¦¨¤é´Á
®É¼Æ
097 
¤þºØ³Ò¤u¦w¥þ½Ã¥Í·~°È¥DºÞ¦w¥þ½Ã¥Í±Ð¨|°V½m 
¥xÆW¬Ù¦w¥þ½Ã¥Í±Ð¨|¨ó·| 
¶i­×¬ã²ß 
 
°ê¤º 
°Ñ¥[ 
2008/11/10 
2008/11/17 
12 
097 
2008»O¤é³J¥Õ½èÅé¾Ç¬ã°Q·| 
»OÆW³J¥ÕÅé¾Ç·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
°ê¤º 
°Ñ¥[ 
2008/12/03 
2008/12/05 
12 
097 
²Ä24©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
°ê¤º 
°Ñ¥[ 
2009/03/21 
2009/03/22 
097 
§K¬Ì¯e¯f·ÓÅ@¬ã²ß·| 
ªø©°§Þ³N¾Ç°|¹Å¸q¤À³¡ 
¶i­×¬ã²ß 
 
°ê¤º 
¥D¿ì 
2009/06/11 
2009/06/12 
16 
098 
¹êÃÒÅ@²z¾Ç:¶q¤Æ¬ã¨s(Evidence-based Nursing: A Quantitative Perspective) 
ªø©°§Þ³N¾Ç°|¹Å¸q¤À³¡ 
¶i­×¬ã²ß 
 
°ê¤º 
¥D¿ì 
2009/11/13 
2009/11/13 
098 
¥tÃþÀøªkªºÃÀ³N¡X¹B¥ÎªÚ­»Àøªk©óºC©Ê·ÓÅ@ 
¹Å¸q¤À³¡Å@²z¨t 
¶i­×¬ã²ß 
 
°ê¤º 
¥D¿ì 
2010/04/01 
2010/04/02 
12 
099 
°ê»Úªø´Á·ÓÅ@¾÷ºc¸gÀç:ºÞ²z «OÀI»P¸ê·½¹B¥Î 
ªø©°§Þ³N¾Ç°| 
¬ã²ß 
 
°ê¤º 
¥D¿ì 
2010/10/21 
2010/10/22 
16 
099 
ÂàĶÂå¾Ç¬ã°Q·|º[¥xÆW³J¥Õ½èÅé¾Ç·|¦~·| 
°ê¥ß¶§©ú¤j¾Ç 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
°ê¤º 
°Ñ¥[ 
2011/04/27 
2011/04/28 
16 
099 
±Ð®v&¾Ç¥Í¤§ªÀ¸s¹ï¸Ü¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç±M®×¿ì¤½«Ç 
¬ã²ß 
 
°ê¤º 
°Ñ¥[ 
2011/06/09 
2011/06/09 
100 
¤¤ÂåÅ@²z¹êÃÒÁͶՠ
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì»Ú¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
½Ð¿ï¾Ü 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2011/10/27 
2011/10/28 
16 
100 
°·±d«O¨x±Ð®v¬ã¨sªÀ¸s 
§d»ñ¬ì§Þ¤j¾Ç 
¾Ç³N¬ã°Q·| 
¨ä¥L§Î¦¡ 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2012/01/04 
2012/01/04 
100 
²Ä27©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·|  
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·|  
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2012/03/17 
2012/03/18 
16 
100 
±Ð®v±Ð¾Ç¼W¯àªÀ¸s¦¨ªGµoªí·| 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2012/06/29 
2012/06/29 
101 
¤HÅé¸ÕÅç¬ã¨s¤H­ûÁ¿²ß¯Z°Ñ¥[ÃÒ©ú 
ªø©°ÂåÀø°]¹Îªk¤H¤HÅé¸ÕÅç­Û²z©e­û·| 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2012/08/18 
2012/08/18 
101 
¯e¯f¤§µoª¢¤ÏÀ³»PÁ{§É·ÓÅ@¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2012/10/25 
2012/10/26 
16 
101 
The Experiences Of Tobacco Use Among Adolescent Boys After Smoking-Cessation Programs 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/01/22 
2013/01/22 
101 
¤÷¥À¿ËªÀ¸g¦a¦ì»P°ê¤¤¥ÍªÎ­D¤§±´°Q¡G¥H2011¦~¥xÆWÀç¾i°·±d½Õ¬d¸ê®Æ¬°¨Ò 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/02/27 
2013/02/27 
101 
²Ä28©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/03/23 
2013/03/24 
16 
101 
¸ê¦wÁ¿²ß½Òµ{¦w¥þ¤Wºô¾Þ§@¤Î¨¾½d¹q¤l¶l¥óªÀ¥æ¤uµ{¦w¥þ«Å¾É 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¹Å¸q¤À³¡¹qºâ¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/03/28 
2013/03/28 
101 
°·±d»P¥Í¬¡«~½è¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/04/18 
2013/04/19 
16 
101 
International Bone and Mineral Society and The Japanese Society for Bone and Mineral Research 
The International Bone and Mineral Society 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2013/05/28 
2013/06/01 
40 
101 
¾³õ¹ê²ß©ÊÄÌÂZ¤§¨¾ªv»P³B¸m¬ã°Q·| 
ªø©°¬ì§Þ¤j¾Ç©Ê§O¥­µ¥±Ð¨|©e­û·| 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/06/05 
2013/06/05 
2.5 
101 
¥ÀÀ¦·ÓÅ@ªº±À¤â-¥H¤f­z¾ú¥v¬ã¨sªk±´¨s¾Ô«áªº²£±C¥Í²P(1921-1989) 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/06/20 
2013/06/20 
102 
Pulmonary rehabilitation research in Taiwan¡GPast, Present, & Future Challenge 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/08/21 
2013/08/21 
102 
¯S±Ðª¾¯à¬ã°Q·|ij-¡mADHD¾Ç¥Íªºµo±¸»P¤¶¤J¡n 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ¾Ç°È³B¿Ô°Ó¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/09/04 
2013/09/04 
102 
ÃöÃh¾Ç¥Í±¡ºü¾AÀ³»P¦Û¶Ë¦æ¬°ªº¹w¨¾»²¾É 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡ ¾Ç°È²Õ 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/09/04 
2013/09/04 
102 
°·±d¸ê®Æ®w©óÁ{§ÉÀ³¥Î¬ã²ß·| 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/10/24 
2013/10/25 
16 
102 
¦h¤¸¾Ç²ßµû¶q¦¨ªGµoªí·| 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç±Ð°È³B 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/10/31 
2013/10/31 
102 
¦h¤¸¾Ç²ßµû¶q±M®a®y½Í·| 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç ±Ð°È³B 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/10/31 
2013/10/31 
4.5 
102 
102 ¦~«×¡u·L§K¤ÎÀËÅçÂå¾Ç¡vº[¡u¥Í¤Æ¤ÎÃIJzÂå¾Ç¡v¸ó¾Çªù¾Ç³N¥æ¬y¬ã°Q·| 
¦æ¬F°|°ê®a¬ì¾Ç©e­û·| 
¾Ç³N¬ã°Q·| 
¨ä¥L§Î¦¡ 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2013/11/02 
2013/11/02 
102 
²Ä29©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2014/03/15 
2014/03/16 
16 
102 
¤HÅé¸ÕÅç¬ã¨s¤H­ûÁ¿²ß¯Z 
ªø©°ÂåÀø°]¹Îªk¤H¹Å¸qªø©°¬ö©ÀÂå°| 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2014/05/10 
2014/05/10 
102 
2014²Ä¤G©¡§Þ³N³Ð§@¤j½à 
¤¤µØ¥Íª«¸ê·½À³¥Î¨ó·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2014/05/25 
2014/05/25 
102 
ICBPS 2014: International Conference on Biomedicine and Pharmaceutical Sciences 
World Academy of Science , Engineering And Technology (WASET) 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2014/05/29 
2014/05/30 
16 
103 
©I§l·ÓÅ@¨t~¹êÃÒÂå¾Ç¤§¾Ç²ß»P«ü¾É¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡©I§l·ÓÅ@¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2014/10/18 
2014/10/18 
103 
¤¤¯óÃÄ»PÃĥίuµß¶}µo¦bÁ{§ÉÂåÅ@À³¥Î¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2014/10/23 
2014/10/24 
16 
103 
²Ä¤G¤Q¤T©¡²Ó­M¤Î¤À¤l¥Íª«·sª¾¬ã°Q·| 
¤¤µØ¥Á°ê²Ó­M¤Î¤À¤l¥Íª«¾Ç¾Ç·|¡B°]¹Îªk¤H°ê®a½Ã¥Í¬ã¨s°| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2015/02/04 
2015/02/06 
24 
103 
²Ä30©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2015/03/21 
2015/03/22 
16 
103 
¤HÅé¸ÕÅç»P¨ü¸ÕªÌ«OÅ@­Û²z¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2015/04/24 
2015/04/24 
103 
2015 International Congress on Chemical, Biological and Environmental Sciences 
Higher Education Forum 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2015/05/07 
2015/05/09 
24 
103 
¼Æ¦ì±Ð¾Ç±M®a®y½Í·| 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2015/06/11 
2015/06/11 
104 
°·«O¸ê®Æ®wÀ³¥Î»P®i±æ 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
¨ä¥L§Î¦¡ 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2015/10/23 
2015/10/23 
104 
°ê»ÚÂåÀø¤ÎªÀ°Ï°·±d«P¶i¤À¨É 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
¨ä¥L§Î¦¡ 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2015/10/23 
2015/10/23 
104 
²Ä31©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2016/03/26 
2016/03/27 
16 
104 
¯f¤H¦w¥þ²z½×»P¹ê°ÈÀ³¥Î¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2016/04/21 
2016/04/22 
16 
104 
¸ê¦wÁ¿²ß½Òµ{-2016­Ó¸ê¥~¬ª¹ê°È®×¨Ò¨¾Å@½g 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¹Ï¸ê²Õ 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2016/04/29 
2016/04/29 
104 
¤p¦Ó¬ü¡G·L¾Ç¤À»P·L«¬½Òµ{ 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2016/05/23 
2016/05/23 
4.5 
104 
ªø´Á·ÓÅ@ªA°È²{ªp»Pµo®i¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç©I§l·ÓÅ@¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2016/06/03 
2016/06/03 
104 
The 39th Annual Meeting of the Japan Neuroscience Society 
The Japan Neuroscience Society (JNS) 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2016/07/20 
2016/07/22 
24 
105 
²Ä¤T¤Q¤G©¡¥Íª«®L¥OÀç 
°ê¥ß¦¨¥\¤j¾ÇÂå¾Ç°|¡B¬ì§Þ³¡¥Í©R¬ì¾Ç¬ã¨s±À°Ê¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2016/08/04 
2016/08/06 
24 
105 
¼Æ¦ì±Ð»P¾Ç©óÅ@²z¤§À³¥Î¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2016/10/20 
2016/10/21 
16 
105 
¾Ç³N­Û²z¬ã²ß 
ªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/02/24 
2017/02/24 
105 
²Ä32©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/03/25 
2017/03/26 
16 
105 
©Ê§O¥­µ¥»P°·±d·ÓÅ@¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/04/27 
2017/04/28 
16 
105 
¬ã¨s­Û²z¬ã¨s·|(§t§Q¯q½Ä¬ðºÞ²z) 
ªø©°¬ì§Þ¤j¾Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/05/12 
2017/05/12 
105 
®Õ¶é¾Ç³N­Û²z 
ªø©°¬ì§Þ¤j¾Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/05/19 
2017/05/19 
105 
1-3-BÅ@²z¼Æ¦ì±Ð§÷À³¥Î¤u§@§{ 
ªø©°¬ì§Þ¤j¾Ç±Ð¾Çµo®i»P¸ê·½¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/06/28 
2017/06/28 
105 
The 40th Annual Meeting of the Japan Neuroscience Society. 
The Japan Neuroscience Society (JNS) 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2017/07/20 
2017/07/23 
24 
106 
²Ä33©¡¥Íª«®L¥OÀç 
°ê¥ß¤¤¿³¤j¾Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/08/23 
2017/08/25 
24 
106 
106¦~«×IACUC©e­û·|©Î¤p²Õ°ò¦°V½m¯Z 
°]¹Îªk¤H¹A·~¬ì§Þ¬ã¨s°| 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/08/29 
2017/08/30 
12 
106 
PBL±Ð¾Çºë¶i¤u§@§{ 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/09/13 
2017/09/13 
106 
Å@²z¤H­ûªk«ß»P³Ò°ÊÅv¯q¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/10/26 
2017/10/27 
16 
106 
3RÆ[ÂI½Í°Êª«¹êÅç·ÓÅ@ 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç¬ã¨sµo®i³B 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/11/03 
2017/11/03 
106 
2017¥Í¤Æ¬î¥OÀç 
¥xÆW¥Íª«¤Æ¾Ç¤Î¤À¤l¥Íª«¾Ç¾Ç·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2017/11/17 
2017/11/19 
16 
106 
106¾Ç¦~«×®v¥Í¹ê°È¼W¯à¸ó®Õ²`«×¹ê°È¬ã²ß­pµe-¤ßªÍ¾i¥Í«O°·»Pªø´Á·ÓÅ@À³¥Î¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç©I§l·ÓÅ@¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/03/08 
2018/04/27 
112 
106 
²Ä33©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
²Ä33©¡¥Íª«Âå¾ÇÁp¦X¦~·|Äw³Æ©e­û·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/03/24 
2018/03/25 
16 
106 
¾É®v»²¾Éª¾¯à¬ã²ß-¤j±M¥Í¨­¤ß¾AÀ³»P»²¾Éµ¦²¤ 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¾Ç°È²Õ 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/04/13 
2018/04/13 
106 
¸ó»â°ì¹êÃÒ¹ê°È¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/04/26 
2018/04/27 
16 
106 
¾·~¦w¥þ½Ã¥Í¦b¾±Ð¨|°V½m 
ªø©°¬ì§Þ¤j¾ÇÀô¹Ò¦w¥þ½Ã¥Í«Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/05/11 
2018/05/11 
106 
ªÅ®ð«~½è¨¾Å@¤u§@§{ 
ªø©°¬ì§Þ¤j¾ÇºC©Ê¯e¯fº[°·±d«P¶i¬ã¨s¤¤¤ß 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/05/17 
2018/05/17 
106 
¤HÅé¸ÕÅç¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/05/23 
2018/05/23 
106 
2018°ê»Ú¥Íª«Âå¾Ç¬ã°Q·|&²Ä15©¡«e¤¥Íª«Âå¾Ç·sª¾¬ã°Q·| 
¤¤°êÂåÃĤj¾Ç 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/06/29 
2018/06/30 
16 
106 
The 41st Annual Meeting of the Japan Neuroscience Society 
The Japan Neuroscience Society 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2018/07/26 
2018/07/29 
32 
107 
¦h¤¸¤å¤Æ±Ð¾Ç»PÂåÅ@°ê»Ú²¾°Ê§Q¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2018/10/25 
2018/10/26 
16 
107 
2018¥Í¤Æ¬î¥OÀç 
¥xÆW¥Íª«¤Æ¾Ç¤Î¤À¤l¥Íª«¾Ç¾Ç·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
¥D¿ì 
2018/11/09 
2018/11/11 
24 
107 
²Ä26©¡²Ó­M¤Î¤À¤l¥Íª«·sª¾¬ã°Q·| 
¤¤µØ¥Á°ê²Ó­M¤Î¤À¤l¥Íª«¾Ç¾Ç·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/01/23 
2019/01/25 
16 
107 
«OÅ@´¼¼z°]²£Åv 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡¹Ï¸ê²Õ 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/03/08 
2019/03/08 
107 
2019¦~·|­û¤j·|º[¾÷¯à©Ê­¹«~§ïµ½¥NÁ²§±`»P¦Ñ¤Æ¤§°ê»Ú¬ã°Q·| 
¥xÆW«O°·­¹«~¾Ç·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/03/15 
2019/03/15 
107 
²Ä34©¡¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
²Ä34©¡¥Íª«Âå¾ÇÁp¦X¦~·| 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/03/23 
2019/03/24 
16 
107 
±Ð¾Ç³]­p»P¦h¤¸µû¶q¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/04/25 
2019/04/26 
14 
107 
107¾Ç¦~«×®ü¥~²`«×¹ê°È¬ã²ß¦¨ªG¤À¨É 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/05/15 
2019/05/15 
107 
¤HÅé¬ã¨sº[¨ü¸ÕªÌ«OÅ@½Òµ{¬ã²ß·| 
ªø©°¾Ç®Õ°]¹Îªk¤Hªø©°¬ì§Þ¤j¾Ç 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/06/21 
2019/06/21 
107 
The 42nd Annual Meeting of the Japan Neuroscience Society 
The Japan Neuroscience Society (JNS) 
¾Ç³N¬ã°Q·| 
¤½¶}¼x½Z 
¤é¥» 
°Ñ¥[ 
2019/07/25 
2019/07/28 
32 
108 
²Ä35©¡¥Íª«®L¥OÀç 
¬ì§Þ³¡¥Í©R¬ì¾Ç¬ã¨s±À°Ê¤¤¤ß 
¬ã²ß 
¨ä¥L§Î¦¡ 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/08/25 
2019/08/27 
24 
108 
¥þ­^¤å½Òµ{³]­p»P±Ð¾Ç¬ã²ß·| 
ªø©°¬ì§Þ¤j¾Ç¹Å¸q¤À³¡Å@²z¨t 
¬ã²ß 
 
¥xÆW¡A¤¤µØ¥Á°ê 
°Ñ¥[ 
2019/10/25 
2019/10/25 

©Ó±µ­pµe®×¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
®×¦W
Ãþ«¬
°_©l¤é´Á
µ²§ô¤é´Á
¤u§@Ãþ§O
098 
¥H³J¥Õ½èÅé¤èªk±´¯Á´Óª«©Ê²üº¸»X¥H¤£¦PAÀôßm°ò¨ú¥N¤§Ãþ¶ÀତƦXª«§Ü¤HÅé¤j¸zÀù²Ó­M¤§¬¡©Ê¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2009/11/02 
2011/10/31 
¥D«ù¤H 
098 
¤£¦P¨Ó·½ªº¤HÃþ¶¡½è·F²Ó­M¤§¥\¯à©Ê³J¥Õ½èªí²{¬ã¨s¡G transgelin-2¦b¶¡½è·F²Ó­M¤À¤Æ½Õ±±¤§¬ã¨s 
®Õ¤º¸É§U®×(K) 
2010/03/01 
2011/02/28 
¥D«ù¤H 
098 
Transgelin³J¥Õ¦b¤j¸zµ²¸zÀù²Ó­Mªºªí²{»P±´°Q©Ò§êºt¤§¨¤¦â1/2 
¥ø·~²£¾Ç­pµe(F) 
2010/06/01 
2012/05/31 
¦@¦P¥D«ù¤H 
099 
¥H´Óª«©Ê²üº¸»X¤§Ãþ¶ÀତƦXª«§í¨î¤HÃþ¯×ªÕ²Ó­M¤À¤Æ¤§¬ã¨s(1/2) 
¥ø·~²£¾Ç­pµe(F) 
2010/09/01 
2011/08/31 
¦@¦P¥D«ù¤H 
099 
¤£¦P¤fµÄÀô¹Ò¹ï©ó²Óµß·P¬V³y¦¨¤HÃþ¾¦ÅiÅÖºû¥À²Ó­Mµoª¢¤§¤À¤l¾÷¨î»PÃþ¶ÀତƦXª«§Üµoª¢¤§¬ã¨s(1/2) 
¥ø·~²£¾Ç­pµe(F) 
2010/09/01 
2011/08/31 
¦@¦P¥D«ù¤H 
099 
¥H³J¥Õ½èÅé¤èªk±´¯Á´Óª«©Ê²üº¸»X¥H¤£¦PAÀôßm°ò¨ú¥N¤§Ãþ¶ÀତƦXª«§Ü¤HÅé¤j¸zÀù²Ó­M¤§¬¡©Ê¬ã¨s(2/2) 
®Õ¤º¸É§U®×(K) 
2010/11/01 
2011/10/31 
¥D«ù¤H 
099 
·s¿oÀù¯g¥Íª««ü¼Ð¡G Transgelin ³J¥Õ¦b EGF ½Õ±±°T®§¶Ç»¼路®|³y¦¨ ¤j¸zª½¸zÀù²Ó­M«I¥Ç¤§¬ã¨s(1/2) 
¥ø·~²£¾Ç­pµe(F) 
2011/01/01 
2011/12/31 
¦@¦P¥D«ù¤H 
099 
½Õ¸`©Ê T²Ó­M»¤¾É¤j¸zª½¸zÀù²Ó­MÁͤƳJ¥Õ SDF-1¤ÎuPA°ò¦]ªí²{¤§¤À¤l¾÷¨î 
¥ø·~²£¾Ç­pµe(F) 
2011/01/01 
2011/12/31 
¦@¦P¥D«ù¤H 
099 
Visfatin¹ï©ó¤HÃþ¤º¥Ö«eÅX²Ó­M¥\¯à¤Î°ò¦]ªí²{¤§¼vÅT 
¥ø·~²£¾Ç­pµe(F) 
2011/01/01 
2011/12/31 
¦@¦P¥D«ù¤H 
099 
transgelin-2¦b¤HÃþ°©Å趡½è·F²Ó­M¥Íªø¤À¤Æ½Õ±±¤§¬ã¨s 
®Õ¤º¸É§U®×(K) 
2011/03/01 
2012/02/29 
¥D«ù¤H 
099 
µUÀYÛ£²£«~©µ½w°I¦Ñ¥\¯àµû¦ô¸ÕÅç 
¥ø·~²£¾Ç­pµe(F) 
2011/04/01 
2013/03/31 
¥D«ù¤H 
099 
Transgelin³J¥Õ¦b¤j¸zµ²¸zÀù²Ó­Mªºªí²{»P±´°Q©Ò§êºtªº¨¤¦â(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2011/06/01 
2012/05/31 
¦@¦P¥D«ù¤H 
100 
¤£¦P¤fµÄÀô¹Ò¹ï©ó²Óµß·P¬V³y¦¨¤HÃþ¾¦ÅiÅÖºû¥À²Ó­Mµoª¢¤§¤À¤l¾÷¨î»PÃþ¶ÀତƦXª«§Üµoª¢¤§¬ã¨s(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2011/09/01 
2012/08/31 
¦@¦P¥D«ù¤H 
100 
¥H´Óª«©Ê²üº¸»X¤§Ãþ¶ÀତƦXª«§í¨î¤HÃþ¯×ªÕ²Ó­M¤À¤Æ¤§¬ã¨s(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2011/09/01 
2012/08/31 
¦@¦P¥D«ù¤H 
100 
¯×ªÕ¿E¯À»¤¾É­GÀù²Ó­Mstromal cell-derived factor-1 (SDF-1)°ò¦]ªí²{¤§¤À¤l¾÷¨î 
¥ø·~²£¾Ç­pµe(F) 
2011/09/01 
2012/08/31 
¦@¦P¥D«ù¤H 
100 
¤HÃþ°©Å趡ª½·F²Ó­M»PÂÀ±a°ò½è·F²Ó­M¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s:transgelin-2¦b¶¡½è·F²Ó­M¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s(1/3) 
¥ø·~²£¾Ç­pµe(F) 
2011/11/01 
2012/10/31 
¥D«ù¤H 
100 
½Õ¸`©ÊT²Ó­M»¤¾É¤j¸zª½¸zÀù²Ó­MÁͤƳJ¥ÕSDF-1¤ÎuPA°ò¦]ªí²{¤§¤À¤l¾÷¨î(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2012/01/01 
2012/12/31 
¦@¦P¥D«ù¤H 
100 
·s¿oÀù¯g¥Íª««ü¼Ð¡G Transgelin ³J¥Õ¦b EGF ½Õ±±°T®§¶Ç»¼路®|³y¦¨ ¤j¸zª½¸zÀù²Ó­M«I¥Ç¤§¬ã¨s(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2012/01/01 
2012/12/31 
¦@¦P¥D«ù¤H 
101 
¤HÃþ°©Å趡½è·F²Ó­M»PÂÀ±a°ò½è·F²Ó­M¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s¡Gtransgelin-2¦b¶¡½è·F²Ó­M¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2012/11/01 
2013/10/31 
¥D«ù¤H 
101 
¥H³J¥Õ½èÅé¤èªk¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤­·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2012/11/01 
2013/10/31 
¥D«ù¤H 
101 
¥H³J¥Õ½èÅé¤èªk¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤­·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2012/11/01 
2013/10/31 
¥D«ù¤H 
101 
¥H³J¥Õ½èÅé¤èªk¬ã¨sµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤­·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2013/01/01 
2013/12/31 
¦@¦P¥D«ù¤H 
101 
±´°Q½Õ¸`©ÊT²Ó­M»¤¾Éµoª¢°ò¦]ªí²{³y¦¨¤j¸zª½¸zÀù²Ó­M«I¥Ç¾÷¨î¤Wªº¼vÅT 
¥ø·~²£¾Ç­pµe(F) 
2013/03/01 
2013/12/31 
¦@¦P¥D«ù¤H 
101 
±´°Q°ª¿}Àô¹Ò¤U¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²Ó­M¦b·P¬V¾÷¨î¤Wªº¼vÅT 
®Õ¤º¸É§U®×(K) 
2013/03/31 
2013/11/30 
¥D«ù¤H 
101 
±´°Q°ª¿}Àô¹Ò¤U¤ú¶g¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²Ó­M¦b·P¬V¾÷¨î¤Wªº¼vÅT 
¥ø·~²£¾Ç­pµe(F) 
2013/04/01 
2014/03/31 
¥D«ù¤H 
102 
µUÀYÛ£µßµ·Åéµo»Ã¤§µÑ¨úª«§Ü¤j¸zÀù¬¡©Ê©M¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¾Ç±´¯Á¨ä§Ü¤j¸zÀù¥Íª«¼Ð°O 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2013/08/01 
2014/07/31 
¥D«ù¤H 
102 
¥H³J¥Õ½èÅé¤èªk±´¯Át-BHP»¤¾É¨xŦ²Ó­M·l¶Ë¤§¥Íª««ü¼Ð¤Î¨xª¢³J¥Õªºªí²{¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2013/10/01 
2014/09/30 
¦@¦P¥D«ù¤H 
102 
¤HÃþ°©Å趡½è·F²Ó­M»PÂÀ±a°ò½è·F²Ó­M¤§¥\¯à©Ê³J¥Õ½èÅé¬ã¨s¡Gtransgelin-2¦b¶¡½è·F²Ó­M¥Íªø»P¤À¤Æ½Õ±±¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2013/11/01 
2014/10/31 
¥D«ù¤H 
102 
¥H³J¥Õ½èÅé¤èªk¬ã¨sµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤­·ªº«OÅ@¾÷Âध¬¡©Ê¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2014/01/01 
2014/12/31 
¦@¦P¥D«ù¤H 
102 
±´°Q½Õ¸`©ÊT²Ó­M»¤¾Éµoª¢°ò¦]ªí²{³y¦¨¤j¸zª½¸zÀù²Ó­M«I¥Ç¾÷¨î¤Wªº¼vÅT(2/3) 
¥ø·~²£¾Ç­pµe(F) 
2014/03/01 
2015/02/28 
¦@¦P¥D«ù¤H 
102 
±´°Q°ª¿}Àô¹Ò¤U¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²Ó­M¦b·P¬V¾÷¨î¤Wªº¼vÅT(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2014/04/01 
2015/03/31 
¥D«ù¤H 
102 
µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s 
¬F©²²£¾Ç­pµe(B) 
2014/06/01 
2015/05/31 
¥D«ù¤H 
102 
µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2014/06/01 
2015/12/31 
¥D«ù¤H 
103 
¯×ªc¯Àresistin»¤¾É¤HÃþ­GÀù²Ó­MÂಾ¯à¤OSDF-1°ò¦]ªí²{¤§¾÷Âà¬ã¨s(1/3) 
¥ø·~²£¾Ç­pµe(F) 
2014/08/01 
2015/07/31 
¦@¦P¥D«ù¤H 
103 
µUÀYÛ£µßµ·ÅéµUÀY¯À§í¨î¤j¸zÀù²Ó­MÂಾ«Iŧ¤§¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¾Ç±´¯Á¨ä§Ü¤j¸zÀù¤§¼Ð¹v¤À¤l 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2014/08/01 
2015/07/31 
¥D«ù¤H 
103 
µUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¹êÅç©Ê¸£¥~¶Ë°Êª«¯«¸g¤¸Ãa¦º¤§¦A¥Í¾÷Âध¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2014/11/01 
2015/10/31 
¥D«ù¤H 
103 
´Óª«ÆPCIL-102§í¨î¤j¸zÀù¥Íªø©M¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯Á¨ä§Ü¤j¸zÀù¤§¼Ð¹v¤À¤l(1/3) 
¥ø·~²£¾Ç­pµe(F) 
2014/12/01 
2015/11/30 
¦@¦P¥D«ù¤H 
103 
±´°Q°ª¿}»¤¾É¤ú©P¯fµß¹ï¤HÃþ¾¦ÅiÅÖºû¥À²Ó­M°ò¦]ªí²{¦b·P¬V¾÷¨î¤Wªº¼vÅT 
¥ø·~²£¾Ç­pµe(F) 
2015/04/01 
2016/03/31 
¥D«ù¤H 
103 
¡i¾ã¦X«¬­p¹º¡j¤t±T¯g§K¬Ì­P¯f¾÷Âà¬ã¨s:¤l­pµe¤T:¤t±T¯g¦å²M¹ï©ó²O¤Ú²Ó­MCD40/BLK/FCGR2A»P¦åºÞ²Ó­Mµoª¢¤ÏÀ³¤§¼vÅT»P±´°Q©Ò§êºt¤§¨¤¦â 
¥ø·~²£¾Ç­pµe(F) 
2015/04/01 
2016/04/30 
¥D«ù¤H 
104 
¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç ½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(1/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2015/08/01 
2016/07/31 
¥D«ù¤H 
104 
§ÜÃĩʤj¸zÀù·F²Ó­M®è¤§§ÜÃľ÷¨î¬ã¨s»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯Á¤j¸zÀù·F²Ó­M»¤¾Éµoª¢³J¥Õªí²{»P½Õ±±«I¥Ç¾÷¨î¤Wªº¼vÅT 
¥ø·~²£¾Ç­pµe(F) 
2015/08/01 
2016/07/31 
¥D«ù¤H 
104 
À³¥Î¬¡Åé¥ú¾Ç¦¨¹³»P³J¥Õ½èÅé¾Ç§Þ³N±´¯ÁµUÀYÛ£­xµ·Åéµo»ÃµÑ¨úª«¹ï©¬ª÷´Ë¤ó¯g°Êª««OÅ@¾÷Âध¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2016/06/01 
2017/05/31 
¥D«ù¤H 
105 
¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(2/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2016/08/01 
2017/07/31 
¥D«ù¤H 
105 
±´°Q¤ú©P¯f·P¬V¦åºÞ²Ó­M½Õ±±TLR¤Îintegrin°T®§¶Ç»¼³y¦¨°Ê¯ßµw¤Æ¾÷¨î 
¥ø·~²£¾Ç­pµe(F) 
2016/11/01 
2017/10/31 
¥D«ù¤H 
105 
¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþ­GÀù²Ó­MÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(1/3) 
¥ø·~²£¾Ç­pµe(F) 
2017/01/01 
2017/12/31 
¥D«ù¤H 
106 
¹B¥Î³J¥Õ½èÅé¾Ç±´°QµUÀYµßµßµ·Åéµo»Ãª«§í¨î¤j¸zÀù¤§¼Ð¹v³J¥Õ¥\¯à»PªíÆ[¿ò¶Ç½Õ±±ªº¬ÛÃö©Ê¾÷¨î¬ã¨s(3/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2017/08/01 
2018/07/31 
¥D«ù¤H 
106 
Ua¯à¶q°·±d¤ì»s«~¹ï°ª¦åÀ£±wªÌªººÎ¯v»Ùê»P¥Í¬¡«~½èÁ{§É¸ÕÅç­p¹º 
¥ø·~²£¾Ç­pµe(F) 
2017/10/01 
2018/09/30 
¥D«ù¤H 
106 
±´°Q¤ú©P¯f·P¬V¦åºÞ²Ó­M½Õ±±TLR¤Îintegrin°T®§¶Ç»¼³y¦¨°Ê¯ßµw¤Æ¾÷¨î(2/2) 
¥ø·~²£¾Ç­pµe(F) 
2017/11/01 
2018/10/31 
¥D«ù¤H 
106 
µUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¦h¤ÚÓi¯«¸g²Ó­M°ö¾i»PµUÀY¯À¹ï¤Úª÷´Ë¤ó¯g°Êª«ªvÀø®ÄªGµû¦ô 
¥ø·~²£¾Ç­pµe(F) 
2018/01/01 
2019/12/30 
¥D«ù¤H 
106 
¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþ­GÀù²Ó­MÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(2/3) 
¥ø·~²£¾Ç­pµe(F) 
2018/01/01 
2018/12/31 
¥D«ù¤H 
107 
·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþ­GÀù²Ó­M¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(1/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2018/08/01 
2019/07/31 
¥D«ù¤H 
107 
¹ñ·s¤ÑµMª«µUÀY¯À¢á§í¨î¤HÃþ­GÀù²Ó­MÂಾ«Iŧ¾÷¨î±´°Q»P¹B¥Î³J¥Õ½èÅé¤èªk±´¯ÁµUÀY¯À³J¥Õªí²{¤§¬ã¨s(3/3) 
¥ø·~²£¾Ç­pµe(F) 
2019/01/01 
2019/12/31 
¥D«ù¤H 
107 
¹B¥Î¬¡Åé¥ú¾Ç¦¨¹³»P³J¥Õ½èÅé¾Ç±´°QÃĥίuµßµUÀY¯À³z¹L PAK¬¡¤Æ¿E酶½Õ¸`°©¬[³J¥Õªº§@¥Î¦Ó§í¨î©¬ª÷´Ë¤ó¯g°Êª«¤§¯«¸g²Ó­M·l¶Ë¾÷¨î±´°Q(1/1) 
¥ø·~²£¾Ç­pµe(F) 
2019/03/01 
2020/02/29 
¥D«ù¤H 
107 
«e¤©ÊµUÀYÛ£µßµ·ÅéµÑ¨úª«µUÀY¯À³z¹L PAK1¬¡¤Æ¿E酶¹ïªvÀø¤j¹«³Ð¶Ë©Ê¸£·l¶Ë¤§¬ã¨s 
¬F©²²£¾Ç­pµe(B) 
2019/06/01 
2020/05/31 
¥D«ù¤H 
107 
«e¤©ÊµUÀYÛ£µßµ·ÅéµÑ¨úª«µUÀY¯À³z¹LPAKI¬¡¤Æ¿E酶¹ïªvÀø¤j¹«³Ð¶Ë©Ê¸£·l¶Ë¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2019/06/01 
2020/05/31 
¥D«ù¤H 
108 
·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþ­GÀù²Ó­M¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(2/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2019/08/01 
2020/07/31 
¥D«ù¤H 
108 
¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²Ó­Mµoª¢¤§¬ã¨s(1/3) 
¥ø·~²£¾Ç­pµe(F) 
2019/12/01 
2020/11/30 
¥D«ù¤H 
108 
°w¹ï¤p¹«¤â³N©Ê³Ð¶Ë¶Ë¤f¤§¥Ö½§¥\¯à«ì´_¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2020/01/01 
2021/12/31 
¥D«ù¤H 
108 
CCLs/CXCLsÁͤƦ]¤l°Ñ»P¸£·L½¦²Ó­M¯«¸gµoª¢°h¤Æ¾÷¨î»P³z¹L¤ÑµMÃĪ« erinacine C¹F¨ì§í¨î®ÄªGªº¬ã¨s(1/2) 
¥ø·~²£¾Ç­pµe(F) 
2020/01/01 
2020/12/31 
¥D«ù¤H 
109 
·s«¬µUÀYµß²GºAµo»ÃµÑ¨úª«µUÀY¯À§í¨î¤HÃþ­GÀù²Ó­M¤§¾÷¨î»PªíÆ[¿ò¶Ç½Õ±±¤§¬ã¨s(3/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2020/08/01 
2021/07/31 
¥D«ù¤H 
109 
¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²Ó­Mµoª¢¤§¬ã¨s(2/3) 
¥ø·~²£¾Ç­pµe(F) 
2020/12/01 
2021/11/30 
¥D«ù¤H 
109 
CCLs/CXCLsÁͤƦ]¤l°Ñ»P¸£·L½¦²Ó­M¯«¸gµoª¢°h¤Æ¾÷¨î»P³z¹L¤ÑµMÃĪ« erinacine C¹F¨ì§í¨î®ÄªGªº¬ã¨s(2/2) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2021/01/01 
2021/12/31 
¥D«ù¤H 
109 
¼ÌªÛ¦¨¤À»²§U­°§C¤ÆÀø¥ÎÃľ¯¶q¤§¬ã¨s 
¥ø·~²£¾Ç­pµe(F) 
2021/01/01 
2022/12/31 
¥D«ù¤H 
110 
¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²Ó­M«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2021/08/01 
2022/07/31 
¥D«ù¤H 
110 
¬ì§Þ³¡­pµe(NMRPF6L0031)¬Û¹ï¸É§U20% 
®Õ¤º¸É§U®×(K) 
2021/08/01 
1900/01/00 
¥D«ù¤H 
110 
¤ÑµMª«µÑ¨ú¤p¤À¤lµUÀY¯À´î½w¤j¹«³Ð¶Ë©Ê¸£¾_Àú»¤¾É·L½¦½è²Ó­Mµoª¢¤§¬ã¨s(3/3) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2021/12/01 
2022/11/30 
¥D«ù¤H 
111 
¹B¥Îªì¥N¸£²Ó­M°ö¾i¨Ã±´°Q¤p½¦½è²Ó­M§K¬Ì­@¨ü¹Lµ{¤¤§Üµoª¢¾÷¨î»P¯«¸g«OÅ@§@¥Î(1/1) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2022/07/01 
2023/06/30 
¥D«ù¤H 
110 
¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²Ó­M«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s(2/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2022/08/01 
2023/07/31 
¥D«ù¤H 
110 
¬ì§Þ³¡­pµe(NMRPF6L0032)¬Û¹ï¸É§U20% 
®Õ¤º¸É§U®×(K) 
2022/08/01 
 
¥D«ù¤H 
110 
°ê¬ì·|²£¾Ç­pµe(NCRPF6M0011)¬Û¹ï¸É§U50% 
®Õ¤º¸É§U®×(K) 
2022/11/01 
 
¥D«ù¤H 
110 
¥Í²£²GºAµo»Ã·s¿oµUÀY¯À§í¨î¯«¸gÁͤƦ]¤lCCLs/CXCLsªvÀø¥¢´¼¯g¤§¥Î³~ 
¥ø·~²£¾Ç­pµe(F) 
2022/11/01 
2024/10/30 
¥D«ù¤H 
110 
¥Í²£²GºAµo»Ã·s¿oµUÀY¯À§í¨î¯«¸gÁͤƦ]¤lCCLs/CXCLs ªvÀø¥¢´¼¯g¤§¥Î³~ 
¬F©²²£¾Ç­pµe(B) 
2022/11/01 
2023/10/31 
¥D«ù¤H 
110 
»OÆWòÔ²GºAµo»ÃµÑ¨úª«¹ï©ó¤j¹«°ª¦åÀ£¤Î¦åºÞ©Ê¥¢´¼¯g¤§«OÅ@§@¥Î¾÷¨î(1/3) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2022/12/01 
2023/11/30 
¥D«ù¤H 
112 
¹ñ·sµÑ¨úµUÀY¯À§í¨î§ÜÃĩʤj¸zÀù²Ó­M«I¥ÇÂಾ»P½Õ±±ªíÆ[¿ò¶Ç¾÷¨î¤§¬ã¨s(3/3) 
°ê¬ì·|±MÃD¬ã¨s­pµe(D1) 
2023/08/01 
2024/07/31 
¥D«ù¤H 
112 
°ê¬ì·|­pµe20%-NMRPF6L0033 
®Õ¤º¸É§U®×(K) 
2023/08/01 
2024/07/31 
¥D«ù¤H 
112 
¬ì´¶¬¡°Ê¡GSTEMºë·Ç°·±d»â°ì¡X¤k©Ê¬ì¾Ç®a±À¼s­p¹º(¥DÃD¤T)  
¬F©²¨ä¥L®×¥ó(E) 
2023/08/01 
2024/07/31 
¦@¦P(¨ó¦P)¥D«ù¤H 
112 
«Øºc¥þ·s¯«¸g½¦½è²Ó­M¦@°ö¾i¼Ò«¬¨Ó±´°Q¸£¤º¥ý¤Ñ§K¬Ì°O¾Ðªº¤À¤l¾÷¨î¡G¤p½¦½è²Ó­M§K¬Ì­@¨ü»P°V½m§K¬Ì(1/3) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2023/08/01 
2024/07/31 
¥D«ù¤H 
112 
»OÆWòÔ²GºAµo»ÃµÑ¨úª«¹ï©ó¤j¹«°ª¦åÀ£¤Î¦åºÞ©Ê¥¢´¼¯g¤§«OÅ@§@¥Î¾÷¨î(2/3) 
¨ä¥L³æ¦ì²£¾Ç­pµe(H) 
2023/12/01 
2024/11/30 
¥D«ù¤H 

´Á¥Z½×¤å¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
©ÒÄÝ­pµe®×
½×¤å¦WºÙ
¦¬¿ý¤ÀÃþ
§@ªÌ¶¶§Ç
³q°T§@ªÌ
¥Zª«¦WºÙ
µoªí¨÷¼Æ
µoªí´Á¼Æ
µoªí¤ë¥÷
µoªí¦~¥÷
098 
CMRPF680051 
The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fFibrillar collagen 
SCI 
²Ä¤»§@ªÌ 
§_ 
Biomaterials 
31 
15 
05 
2010 
100 
CZRPG880252; CMRPF680051; EZRPF390261 
Use of proteomic differential displays to assess functional discrepancies and adjustments of human bone marrow- and Wharton jelly-derived mesenchymal stem cells 
SCI 
²Ä¤@§@ªÌ 
§_ 
Journal of Proteome Research 
10 
12 
2011 
099 
CZRPG880252¡B CMRPF680051 and EZRPF390261 
Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression 
SCI 
²Ä¤­§@ªÌ 
§_ 
J. Cell. Physiol 
9999 
1-10 
09 
2010 
100 
CZRPG880252¡B CMRPF680052 and EZRPF390261 
Stromal cell-derived factor-1/CXC receptor 4 andƒÒb1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells 
SCI 
²Ä¤Q§@ªÌ 
¬O 
J. Cell. Physiol  
227 
03 
2012 
099 
CZRPG880252¡B CMRPF680051 and EZRPF390261 
Baicalein inhibits the migration and invasive properties of human hepatoma cells 
SCI 
²Ä¤Q§@ªÌ 
¬O 
Toxicol Appl Pharmacol 
255 
07 
2011 
099 
CZRPG880253, CMRPF680052 and EZRPF390261 
High glucose-treated macrophages augment E-selectin expression in endothelial cells 
SCI 
²Ä¤T§@ªÌ 
§_ 
J Biol Chem 
286 
29 
06 
2011 
100 
CZRPG880252¡B CMRPF680051 and EZRPF390261 
Proteomic Analysis of the Effects of Baicalein on Colon-rectal Cancer Cells 
SCI 
²Ä¤@§@ªÌ 
¬O 
Proteomics 
12 
03 
2012 
100 
CZRPG880252¡B CMRPF680051 and EZRPF390261 
Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated Uropathogenic E. coli. 
SCI 
²Ä¤»§@ªÌ 
§_ 
Cell Microbiol 
13 
11 
10 
2011 
100 
CMRPF 680051, CMRPF 680052, EZRPF 6A0021 and EZRPF 390261 
Identification of immunodeficient molecules in neonatal mononuclear cells by proteomics differential displays. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Proteomics 
11 
10 
2011 
101 
CZRPG880252¡BCMRPF680051 and EZRPF390261 
CXC chemokine ligand 12/Stromal cell-derived factor-1 regulates cell adhesion in human colon cancer 
SCI 
²Ä¤C§@ªÌ 
§_ 
J Biomed Sci 
19 
Open 
10 
2012 
101 
CZRPG880252¡BCMRPF680051 and EZRPF390261 
The Inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK 
SCI 
²Ä¤G§@ªÌ 
§_ 
Toxicol Appl Pharmacol 
263 
08 
2012 
101 
µL 
Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes 
SCI 
²Ä¤­§@ªÌ 
§_ 
Arthritis research & therapy 
15 
Open 
04 
2013 
102 
CMRPF6A0072 
Inhibitory effect of liposome-encapsulated anthocyanin on melanogenesis in human melanocytes. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Pharmaceutical Biology 
51 
08 
2013 
101 
CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 
Glycyrrhizin Represses Total Parenteral Nutrition-Associated Acute Liver Injury in Rats by Suppressing Endoplasmic Reticulum Stress 
SCI 
²Ä¤G§@ªÌ 
§_ 
International Journal of Molecular Sciences 
14 
06 
2013 
102 
CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 
Regulation of ICAM-1 expression in gingival fibroblasts infected with high-glucose-treated P. gingivalis 
SCI 
²Ä¤@§@ªÌ 
¬O 
Cellular Microbiology 
15 
10 
10 
2013 
102 
CZRPG880253, CMRPF6A0072, CMRPF6C0031, EZRPF6C0011 and NSC101-2622-B-255-001-CC3 
Quantitative proteomic analysis of the inhibitory effects of CIL-102 on viability and invasiveness in human glioma cells 
SCI 
²Ä¤G§@ªÌ 
§_ 
Toxicology and Applied Pharmacology 
272 
11 
2013 
102 
µL 
The protective effect of luteolin on cytotoxicity and genotoxicity of bisphenol-A-glycidyldimethacrylate in macrophages involved in DNA damage and caspases activation 
SCI 
²Ä¤­§@ªÌ 
¬O 
Life Science Journal 
10 
12 
2013 
102 
CMRPF6A0073, CMRPF6C0031, EZRPF6C0011 NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 
Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach 
SCI 
²Ä¤Q§@ªÌ 
¬O 
Toxicology 
316 
02 
2014 
102 
CMRPF6C0032¡BCMRPF6A0073¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002 and 103-2622-B-255-001-CC3 
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFkappaB signaling pathway in gastric cancer cells. 
SCI 
²Ä¤Q§@ªÌ 
¬O 
J Biomed Sci. 
21 
06 
2014 
102 
CMRPF6A0073¡BCMRPF6C0032¡BEZRPF6C0011, NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002 and MOST103-2622-B-255-001-CC3 
Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells. 
SCI 
²Ä¤C§@ªÌ 
¬O 
J Biomed Sci. 
21 
07 
2014 
103 
CMRPG6C0072, CMRPF6A0073,CMRPF6C0032,,NSC101-2622-B-255-001-CC3, NSC102-2313-B-255-002 and MOST103-2622-B-255-001-CC3 
Protective Effects of Hericium erinaceus Mycelium and Its Isolated Erinacine A against Ischemia-Injury-Induced Neuronal Cell Death via the Inhibition of iNOS/p38 MAPK and Nitrotyrosine 
SCI 
²Ä¤Q§@ªÌ 
¬O 
Int. J. Mol. Sci. 
15 
08 
2014 
103 
CMRPF6A0073¡BCMRPF6C0032¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002 
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Toxicol Appl Pharmacol. 
279 
09 
2014 
103 
CMRPF6A0073¡BCMRPF6C0032¡BNSC101-2622-B-255-001-CC3¡BNSC102-2313-B-255-002¡B MOST103-2622-B-255-001-CC3 
Upregulation of TLRs and IL-6 as a marker in human colorectal cancer. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Int J Mol Sci.  
16 
12 
2014 
103 
µL 
Ethyl acetate extract of Wedelia chinensis inhibits tert-butyl hydroperoxide-induced damage in PC12 cells and D-galactose-induced neuronal cell loss in mice. 
SCI 
²Ä¥|§@ªÌ 
§_ 
BMC Complement Altern Med. 
14 
12 
2014 
103 
CMRPF6A0073, EZRPF6C0011, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 
Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients. 
SCI 
²Ä¤T§@ªÌ 
§_ 
PLoS One. 
11 
11 
2014 
103 
CZRPG880253, CMRPF6A0073, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 
Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells. 
SCI 
²Ä¤T§@ªÌ 
§_ 
J. Cell. Physiol. 
Accepted. 
Accepted. 
09 
2014 
103 
CMRPF6E0011¡BCMRPE0041¡BCMRPE0021¡BMOST103-2622-B-255-001-CC3¡B MOST103-2313-B-255-001 
Global proteomic analysis of brain tissues in transient ischemia brain damage in rats. 
SCI 
²Ä¤G§@ªÌ 
§_ 
International Journal of Molecular Sciences 
16 
05 
2015 
103 
CMRPF6E0021, CMRPF6E0011, NSC101-2622-B-255-001-CC3 and NSC102-2313-B-255-002 
Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes. 
SCI 
²Ä¤T§@ªÌ 
§_ 
BMC Complementary and Alternative Medicine 
15 
03 
2015 
104 
CMRPF6E0011, CMRPF6E0021, MOST101-2622-B-255-001-CC3 and MOST102-2313-B-255-002 
Shear stress modulates resistin-induced CC chemokine ligand 19 expression in human aortic endothelial cells. 
SCI 
²Ä¤T§@ªÌ 
§_ 
Journal of Cellular Physiology 
230 
09 
2015 
103 
CMRPF6A0073,CMRPF6C0032 
Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. 
SCI 
²Ä¤T§@ªÌ 
§_ 
Arthritis & Rheumatology 
67 
03 
2015 
104 
µL 
Upregulation of Bone Morphogenetic Protein-2 Synthesis and Consequent Collagen II Expression in Leptin-stimulated Human Chondrocytes. 
SCI 
²Ä¤»§@ªÌ 
§_ 
PLoS One.  
10 
12 
12 
2015 
104 
CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3,MOST 103-2313-B-255-001 and MOST 104-2320-B-255-003-MY3 
Proteomic analysis of plasma from rats following total parenteral nutrition-induced liver injury. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Proteomics. 
15 
22 
11 
2015 
104 
CMRPF6E0041 
Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. 
SCI 
²Ä¤E§@ªÌ 
§_ 
Int J Mol Sci. 
17 
05 
2016 
104 
µL 
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. 
SCI 
²Ä¤K§@ªÌ 
§_ 
PLoS One. 
11 
05 
2016 
104 
CMRPF6E0041 
Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease. 
SCI 
²Ä¤»§@ªÌ 
§_ 
Medicine (Baltimore).  
95 
17 
04 
2016 
104 
BMRPD42, CMRPF6E0011, CMRPF6E0041,CMRPF6E0021, MOST 103-2622-B-255-001-CC3 and MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 
Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. 
SCI 
²Ä¤@§@ªÌ 
§_ 
J Transl Med. 
14 
03 
2016 
104 
CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3,MOST 103-2313-B-255-001 
Inhibitory effect of Erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21 
SCI 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
J Funct Foods. 
21 
03 
2016 
105 
CMRPF6E0041 
Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease. 
SCI 
²Ä¤C§@ªÌ 
§_ 
BMC Med Genomics. 
9 Suppl 1 
08 
2016 
105 
BMRPD42, CMRPF6E0011, CMRPF6E0021, CMRPF6E0041, MOST 104-2320-B-255 -003 -MY3. 
Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo. 
SCI 
²Ä¤K§@ªÌ 
¬O 
J Transl Med. 
14 
09 
2016 
105 
BMRPD42, CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST104-2320-B-255-003-MY3. 
The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells. 
SCI 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
PLoS One.  
11 
09 
2016 
105 
BMRPD42, CMRPF6C0032, CMRPF6F0031, CMRPF6E0041, CMRPF6E0021, MOST104-2320-B-255-003-MY3. 
Sterol Regulatory Element-Binding Protein-1c Regulates Inflammasome Activation in Gingival Fibroblasts Infected with High-Glucose-Treated Porphyromonas gingivalis. 
SCI 
²Ä¤@§@ªÌ 
§_ 
Front Cell Infect Microbiol. 
12 
2016 
105 
CMRPF6E0011, CMRPF6E0041, CMRPF6E0021, MOST 103-2622-B-255-001-CC3, MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 
A proteomics approach to identifying novel protein targets involved in erinacine A-mediated inhibition of colorectal cancer cells' aggressiveness. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Journal of Cellular and Molecular Medicine 
21 
03 
2017 
106 
CMRPF6F0031,CMRPF6G0011, MOST 103-2622-B-255-001-CC3 and MOST 103-2313-B-255-001 and MOST 104-2320-B-255 -003 -MY3 
A Comparative Proteomic Analysis of Erinacine A's Inhibition of Gastric Cancer Cell Viability and Invasiveness. 
SCI 
²Ä¤@§@ªÌ 
§_ 
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 
43 
08 
2017 
105 
CMRPF6E0041 
Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. 
SCI 
²Ä¤»§@ªÌ 
§_ 
BMC Pharmacol Toxicol 
18 
01 
2017 
105 
CMRPF6D0071, CMRPF6D0072, CMRPF6D0073 
CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45. 
SCI 
²Ä¤T§@ªÌ 
§_ 
PLoS One. 
12 
01 
2017 
106 
CMRPF6E0041 
HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease. 
SCI 
²Ä¤@§@ªÌ 
§_ 
J Mol Cell Cardiol.  
117 
03 
2018 
106 
µL 
Protective effect of black garlic extracts on tert-Butyl hydroperoxide-induced injury in hepatocytes via a c-Jun N-terminal kinase-dependent mechanism. 
SCI 
²Ä¤»§@ªÌ 
§_ 
Exp Ther Med. 
15 
03 
2018 
106 
CMRPF6G0011 
Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes. 
SCI 
²Ä¤K§@ªÌ 
¬O 
Cell Physiol Biochem. 
45 
03 
2018 
107 
BMRPD42, CMRPF6G0011,CMRPF6G0012, CMRPF6G0013, MOST 107-2320-B-255 -001 -MY3 
Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells. 
SCI 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
Cell Physiol Biochem. 
51 
12 
2018 
106 
µL 
Prescription patterns of traditional Chinese medicine amongst Taiwanese children: a population-based cohort study. 
SCI 
²Ä¥|§@ªÌ 
§_ 
BMC Complement Altern Med. 
18 
01 
2018 
107 
µL 
MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. 
SCI 
²Ä¤G§@ªÌ 
§_ 
Int J Med Sci. 
16 
01 
2019 
108 
BMRPD42,MRPF6G0011, CMRPF6G0012, CMRPF6G0013, CMRPF6I0021 
Induction Apoptosis of Erinacine A in Human Colorectal Cancer Cells Involving the Expression of TNFR, Fas, and Fas Ligand via the JNK/p300/p50 Signaling Pathway With Histone Acetylation 
SCI 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
Front Pharmacol 
10 
10 
2019 
107 
µL 
MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice 
SCI 
²Ä¤G§@ªÌ 
§_ 
Int J Mol Sci 
20 
03 
2019 
108 
BMRPD42 
Properties of N-Type GaN Thin Film with Si-Ti Codoping on a Glass Substrate 
SCI 
²Ä¤­§@ªÌ 
¬O 
CRYSTALS 
10 
07 
2020 
108 
BMRPD42, CLRPG8G0591, CMRPG6H0031,CMRPG6H0032, CMRPF6G0011, CMRPF6G0012, CMRPF6G0013,CMRPF6I0021 and MOST 108-2622-B-255-001-CC3 and MOST 107-2320-B-255-001-MY3 
Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson's Disease 
SCI 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
Antioxidants (Basel). 
01 
2020 
109 
µL 
Type II Collagen from Cartilage of Acipenser baerii Promotes Wound Healing in Human Dermal Fibroblasts and in Mouse Skin 
SCI 
²Ä¤T§@ªÌ 
§_ 
Mar Drugs. 
18 
10 
10 
2020 
109 
BMRPD42, CLRPG8G0591, CMRPF6H0011, CMRPF6H0012, CMRPF6H0013, CMRPF6J0081, CMRPF6K0071, MOST 107-2320-B-255 -001 -MY3 and MOST 108-2622-B-255-001-CC3 
Novel regulator role of CIL-102 in the epigenetic modification of TNFR1/TRAIL to induce cell apoptosis in human gastric cancer 
SCI 
²Ä¤Q§@ªÌ 
¬O 
FOOD AND CHEMICAL TOXICOLOGY 
147 
01 
2021 
109 
µL 
Investigation of Zn/Sn ratio for improving the material quality of CZTS thin films with the reduction of Cu2-xS secondary phase 
SCI 
²Ä¤­§@ªÌ 
¬O 
JOURNAL OF ALLOYS AND COMPOUNDS 
09 
2020 
110 
µL 
Investigation of Cu2ZnSnS4 thin film with preannealing process and ZnS buffer layer prepared by magnetron sputtering deposition. 
SCIE 
²Ä¤­§@ªÌ 
¬O 
JOURNAL OF ALLOYS AND COMPOUNDS 
884 
12 
2021 
109 
CMRPF6G0011, CMRPF6G0012, CMRPF6G0013, CMRPF6I0021, CMRPF6J0081 and CMRPF6K0071 
Apoptotic mechanisms of gastric cancer cells induced by isolated erinacine S through epigenetic histone H3 methylation of FasL and TRAIL 
SCIE 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
FOOD & FUNCTION 
12 
04 
2021 
110 
MOST 110-2320-B-255 -005 -MY3 
Ailanthoidol, a Neolignan, Suppresses TGF-beta 1-Induced HepG2 Hepatoblastoma Cell Progression 
SCIE 
²Ä¤»§@ªÌ 
¬O 
BIOMEDICINES 
09 
2021 
109 
µL 
Enhanced antioxidant activity of Chenopodium formosanum Koidz. by lactic acid bacteria: Optimization of fermentation conditions 
SCIE 
²Ä¤@§@ªÌ 
§_ 
PLOS ONE 
16 
05 
2021 
109 
µL 
Improvement of device characteristics of plasma-treated indium gallium zinc oxide thin-film transistors through thermal annealing 
SCIE 
²Ä¤­§@ªÌ 
¬O 
SEMICONDUCTOR SCIENCE AND TECHNOLOGY 
36 
04 
2021 
109 
MOST 110-2320-B-255 -005 -MY3 
Improving Device Characteristics of Dual-Gate IGZO Thin-Film Transistors with Ar-O-2 Mixed Plasma Treatment and Rapid Thermal Annealing 
SCI, SCIE 
²Ä¤­§@ªÌ 
¬O 
MEMBRANES 
12 
01 
2022 
110 
MOST 110-2320-B-255 -005 -MY3. 
Ganoderma formosanum Exopolysaccharides Inhibit Tumor Growth via Immunomodulation 
SCIE 
²Ä¤@§@ªÌ 
§_ 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 
22 
20 
10 
2021 
110 
MOST 107-2320-B-255 -001 -MY3 
Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of Colorectal Cancer Cells by Using the Proteomic Approach 
SCIE 
²Ä¤G§@ªÌ 
§_ 
Biomolecules 
11 
09 
2021 
109 
µL 
Enzymatic degradation of ginkgolic acids by laccase immobilized on core/shell Fe3O4/nylon composite nanoparticles using novel coaxial electrospraying process 
SCIE 
²Ä¤T§@ªÌ 
§_ 
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 
172 
03 
2021 
111 
µL 
Optimal Growth Conditions for Forming c-Axis (002) Aluminum Nitride Thin Films as a Buffer Layer for Hexagonal Gallium Nitride Thin Films Produced with In Situ Continual Radio Frequency Sputtering 
SCIE 
²Ä¤C§@ªÌ 
¬O 
MICROMACHINES 
13 
09 
2022 
110 
MOST 110-2320-B-255-005-MY3 
2D-DIGE-MS Proteomics Approaches for Identification of Gelsolin and Peroxiredoxin 4 with Lymph Node Metastasis in Colorectal Cancer 
SCIE 
²Ä¤K§@ªÌ 
¬O 
CANCERS 
14 
13 
06 
2022 
110 
MOST 110-2320-B-255 -005 -MY3 
Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol 
SCIE 
²Ä¤K§@ªÌ 
¬O 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 
23 
05 
2022 
110 
CMRPF6K0071, CMRPF6K0072, ZRRPF6L0011 
Neuron-Microglia Contacts Govern the PGE(2) Tolerance through TLR4-Mediated de Novo Protein Synthesis 
SCIE 
²Ä¤@§@ªÌ 
§_ 
BIOMEDICINES 
10 
02 
2022 
110 
BMRPD42, CMRPF6J0081,CMRPF6J0082, CMRPF6K0071, and CMRPF6K0072 
Identification of early response to hypertonic dextrose prolotherapy markers in knee osteoarthritis patients by an inflammation-related cytokine array 
SCIE 
²Ä¥|§@ªÌ 
¬O 
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 
85 
04 
2022 
111 
µL 
Si¡VSn codoped n-GaN film sputtering grown on an amorphous glass substrate 
SCIE 
²Ä¤­§@ªÌ 
¬O 
SEMICONDUCTOR SCIENCE AND TECHNOLOGY 
38 
05 
2023 
111 
BMRPD42,MOST 110-2320-B-255-005-MY3 
Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma 
SCI, SCIE 
²Ä¤E§@ªÌ 
¬O 
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 
27 
14 
06 
2023 
111 
BMRPD42, CMRPF6L0061, CMRPF6L0062, CMRPF6L0063, ZRRPF6M0011, CMRPF6M0071, CMRPF6M0072, CMRPF6M0073, MOST 110-2320-B-255 -005 -MY3 
Antrodin C Isolated from Antrodia Cinnamomea Induced Apoptosis through ROS/AKT/ERK/P38 Signaling Pathway and Epigenetic Histone Acetylation of TNF£\ in Colorectal Cancer Cells 
SCI, SCIE 
²Ä¤Q¤@§@ªÌ¥H¤W 
¬O 
Antioxidants 
12 
03 
2023 
112 
µL 
Tolerized Microglia Protect Neurons Against Endotoxin-Induced TNF-£\ Production via an LBP-Dependent Intracellular p38 MAPK Signaling Pathway 
SCIE 
²Ä¤@§@ªÌ 
¬O 
Inflammation 
46 
10 
2023 

¬ã°Q·|½×¤å¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
©ÒÄÝ­pµe®×
½×¤å¦WºÙ
§@ªÌ¶¶§Ç
³q°T§@ªÌ
¬ã°Q·|¦WºÙ
Á|¦æ°ê®a
Á|¦æ«°¥«
¶}©l¤é´Á
µ²§ô¤é´Á
µoªí¦~¥÷
097 
TCVGH-973701A (2/3) 
Baicalein Inhibits Invasion of Human Hepatoma Cell Line, Through the Downregulation of MMP-9, MMP2 and NF-£eB, and Proliferation in Vivo 
²Ä¤@§@ªÌ 
¬O 
¥Íª«Âå¾ÇÁp¦X¾Ç³N¦~·| 
¥xÆW¡A¤¤µØ¥Á°ê 
Taipei 
2009/03/21 
2009/03/22 
2009 
101 
µL 
Resistin-induced expression of SDF-1 through coordinated activation of p38 MAPK and NF kappaB in gastric epithelial carcinoma 
²Ä¤­§@ªÌ 
¬O 
The twenty eighth Joint Annual Conference of Biomedical Sciences 
¥xÆW¡A¤¤µØ¥Á°ê 
Taipei 
2013/03/23 
2013/03/24 
2013 
101 
µL 
Differential Proteomic Display of Mesenchymal Stem Cells Characterizes transgelin-2 and Hsp90ƒÒ as Required Regulation of Proliferation and Differentiation 
²Ä¤@§@ªÌ 
¬O 
International Bone and Mineral Society and The Japanese Society for Bone and Mineral Research 
¤é¥» 
Kobe 
2013/05/28 
2013/06/01 
2013 
102 
µL 
The Inhibitory Effect of Erinacine A From Hericium Erinaceus Mushroom Extracts on The Growth of Human Colorectal Cancer Cells. 
²Ä¤»§@ªÌ 
¬O 
The twenty ninth Joint Annual Conference of Biomedical Sciences 
¥xÆW¡A¤¤µØ¥Á°ê 
¥x¥_ 
2014/03/15 
2014/03/16 
2014 
102 
µL 
Developed 5-Fu and Oxaliplatin chemoresistant human colorectal cancer stem cells and identification of the molecular mechanism in tumorigenesis. 
²Ä¥|§@ªÌ 
¬O 
The twenty ninth Joint Annual Conference of Biomedical Sciences 
¥xÆW¡A¤¤µØ¥Á°ê 
¥x¥_ 
2014/03/15 
2014/03/16 
2014 
102 
µL 
Hericium Erinaceus, a Traditional Herbal Formula, Inhibits Cell Proliferation by Induction of Apoptosis in Human Liver Cancer Cells. 
²Ä¤»§@ªÌ 
¬O 
The twenty ninth Joint Annual Conference of Biomedical Sciences. 
¥xÆW¡A¤¤µØ¥Á°ê 
¥x¥_ 
2014/03/15 
2014/03/16 
2014 
102 
µL 
Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach. 
²Ä¥|§@ªÌ 
¬O 
World Academy of Science , Engineering And Technology (WASET) 
¤é¥» 
ªF¨Ê 
2014/05/29 
2014/05/30 
2014 

µoªí±M®Ñ¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
©ÒÄÝ­pµe®×
±M®ÑÃþ§O
±M®Ñ¦WºÙ
§@ªÌ¶¶§Ç
³q°T§@ªÌ
¨Ï¥Î»y¤å
¥Xª©¤é´Á
¥Xª©ªÀ
ISBN½s¸¹
>>> ¬ÛÃö¸ê®Æ¤£¤½¶} <<<

±M§Q/·s«~ºØ¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¦~«×
©ÒÄÝ­pµe®×
±M§Q/·s«~ºØ¦WºÙ
°Ï°ì
Ãþ«¬
§@ªÌ¶¶§Ç
104 
µL 
ÂIºw«O·Å¸Ë¸m 
°ê¤º 
·s«¬±M§Q 
²Ä¤G§@ªÌ 
104 
µL 
¨ãµµ¥~½u±j«×«ü¥Ü¥\¯àªº¤Æ§©«~®e¾¹ 
°ê¤º 
·s«¬±M§Q 
²Ä¤G§@ªÌ 
104 
µL 
¨¾Å@¦ç 
°ê¤º 
·s«¬±M§Q 
²Ä¤@§@ªÌ 
104 
µL 
¯f©Ð§Y®É©I±Ï¸Ë¸m 
°ê¤º 
·s«¬±M§Q 
²Ä¤@§@ªÌ 
105 
µL 
¦w¥þ°wµ© 
°ê¤º 
·s«¬±M§Q 
²Ä¤K§@ªÌ 
107 
 
¦w¥þ°w¨ã 
°ê¤º 
·s«¬±M§Q 
²Ä¤@§@ªÌ 
109 
µL 
¦Õ·Å®M²° 
°ê¤º 
µo©ú±M§Q 
²Ä¤@§@ªÌ 
109 
µL 
ª`®g°wµ© 
°ê¤º 
µo©ú±M§Q 
²Ä¤@§@ªÌ 
109 
µL 
§l¤J©Ê¼QÃú¾¹ 
°ê¤º 
µo©ú±M§Q 
²Ä¤@§@ªÌ 
110 
µL 
¯ÝºÞ³¬Âê¸Ë¸m 
°ê¤º 
µo©ú±M§Q 
²Ä¤@§@ªÌ 
112 
µL 
½¦±a¸Ë¸m 
°ê¤º 
µo©ú±M§Q 
²Ä¤@§@ªÌ 

Àò¹{¼ú¶µ»PºaÅA¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )

¦~«×
©ÒÄÝ­pµe®×
¦WºÙ
°ê§O
¾÷ºc¦WºÙ
¤é´Á
098 
CMRPF680051 
Âå¾Ç¬ã¨s½×¤å¼ú Poster Award 
¥xÆW¡A¤¤µØ¥Á°ê 
Taiwan Proteomics Society 
2010/04/24 
100 
µL 
99¾Ç¦~«×ªø©°¬ì§Þ¤j¾Ç¬ã¨sÁZÀu±Ð®v 
¥xÆW¡A¤¤µØ¥Á°ê 
ªø©°¬ì§Þ¤j¾Ç 
2011/09/23 
102 
µL 
101¾Ç¦~«×²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu±Ð®v¼ú 
¥xÆW¡A¤¤µØ¥Á°ê 
ªø©°¬ì§Þ¤j¾Ç 
2013/09/26 
104 
µL 
103¾Ç¦~«×²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu¼ú 
¥xÆW¡A¤¤µØ¥Á°ê 
ªø©°¬ì§Þ¤j¾Ç 
2015/09/28 
106 
µL 
105¾Ç¦~«×ªø©°¬ì§Þ¤j¾Ç²£¾Ç¦X§@§Þ³N¬ãµoÁZÀu±Ð®v¼ú 
¥xÆW¡A¤¤µØ¥Á°ê 
ªø©°¬ì§Þ¤j¾Ç 
2017/09/28 
107 
µL 
ªø©°¬ì§Þ¤j¾Ç106¾Ç¦~«×¾Ç³N§@«~µoªíÁZÀu¼ú 
¥xÆW¡A¤¤µØ¥Á°ê 
ªø©°¬ì§Þ¤j¾Ç 
2018/09/28 
±Ð®v§Þ³N²¾Âà©Î±ÂÅv¦Cªí
( ÂI¿ï¸ê®Æ¦C¡A§Y¥iÂsÄý§ó¸Ô²Óªº¤º®e¡I )
¾Ç¦~«×
§Þ³N²¾Âà©Î±ÂÅv
§ÞÂà©Î±ÂÅv¦WºÙ
§Þ³N²¾Âà©Î±ÂÅv¼t°Ó¦WºÙ
§Þ³N²¾Âàª÷ÃB©Î±ÂÅvª÷ÃB
§Þ³N²¾Âà©Î±ÂÅv°_©l¤é´Á
§Þ³N²¾Âà©Î±ÂÅv²×¤î¤é´Á
§Þ³N²¾Âà©Î±ÂÅv¦X¬ù½s¸¹
¬O§_¨ú±o±M§Q
±M§QÃҮѦr¸¹
101 
§Þ³N²¾Âà 
¶}µoµUÀYÛ£µßµ·ÅéµÑ¨úª«¹ï¤j¹«¯Ê¦å©Ê¸£¤¤­·ªº«OÅ@¾÷Âध¬¡©Ê 
¸²µå¤ý¥Í§ÞªÑ¥÷¦³­­¤½¥q 
100000 
20121101 
20131031 
NCRPF6B0011 
§_ 
 
102 
§Þ³N²¾Âà 
µUÀYÛ£µßµ·ÅéµÑ¨úª«½Õ¸`¤º½èºôÀ£¤O°T¸¹¹ï¤Úª÷´Ë¤ó¯g°Êª«¯«¸g¤¸Ãa¦º¤Î¦æ¬°¯Ê³´¤§«OÅ@¾÷Âध¬ã¨s 
¸²µå¤ý¥Í§ÞªÑ¥÷¦³­­¤½¥q 
100000 
20140601 
20150531 
NCRPF6D0011 
§_